Lovenox (enoxaparin sodium) Injection

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved January 1999

Specific Treatments:

Hematology

Therapeutic Areas

General Information

Lovenox has been approved for the following indications: (1) the inpatient treatment of acute deep vein thrombosis with and without pulmonary embolism, when administered in conjunction with warfarin sodium, and (2) the outpatients treatment of acute deep vein thrombosis without pulmonary embolism when administered in conjunction with warfarin sodium.